Literature DB >> 11942033

Oxygenation measurements in head and neck cancers during hyperbaric oxygenation.

Axel Becker1, Thomas Kuhnt, Hendrik Liedtke, Andreas Krivokuca, Marc Bloching, Jürgen Dunst.   

Abstract

BACKGROUND: Tumor hypoxia has proven prognostic impact in head and neck cancers and is associated with poor response to radiotherapy. Hyperbaric oxygenation (HBO) offers an approach to overcome hypoxia. We have performed pO2 measurements in selected patients with head and neck cancers under HBO to determine in how far changes in the oxygenation occur and whether a possible improvement of oxygenation parameters is maintained after HBO. PATIENTS AND METHODS: Seven patients (five male, two female, age 51-63 years) with squamous cell cancers of the head and neck were investigated (six primaries, one local recurrence). The median pO2 prior to HBO was determined with the Eppendorf histograph. Sites of measurement were enlarged cervical lymph nodes (n = 5), the primary tumor (n = 1) and local recurrence (n = 1). Patients then underwent HBO (100% O2 at 240 kPa for 30 minutes) and the continuous changes in the oxygenation during HBO were determined with a Licox probe. Patients had HBO for 30 minutes (n = 6) to 40 minutes (n = 1). HBO was continued because the pO2 had not reached a steady state after 30 minutes. After decompression, patients ventilated pure oxygen under normobaric conditions and the course of the pO2 was further measured over about 15 minutes.
RESULTS: Prior to HBO, the median tumor pO2 in the Eppendorf histography was 8.6 +/- 5.4 mm Hg (range 3-19 mm Hg) and the pO2 measured with the Licox probe was 17.3 +/- 25.5 mm Hg (range 0-73 mm Hg). The pO2 increased significantly during HBO to 550 +/- 333 mm Hg (range 85-984 mm Hg, p = 0.018). All patients showed a marked increase irrespective of the oxygenation prior to HBO. The maximum pO2 in the tumor was reached after 10-33 minutes (mean 17 minutes). After leaving the hyperbaric chamber, the pO2 was 282 +/- 196 mm Hg. All patients maintained an elevated pO2 for further 5-25 minutes (138 +/- 128 mm Hg, range 42-334 mm Hg, p = 0.028 vs the pO2 prior to HBO).
CONCLUSIONS: Hyperbaric oxygenation resulted in a significant increase in the tumor oxygenation in all seven investigated patients. A significant increase at the point of measurement could be maintained for several minutes after decompression and after leaving the hyperbaric chamber.

Entities:  

Mesh:

Year:  2002        PMID: 11942033     DOI: 10.1007/s00066-002-0892-0

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  11 in total

Review 1.  Direct cerebral oxygenation monitoring--a systematic review of recent publications.

Authors:  Erhard W Lang; Jamin M Mulvey; Yugan Mudaliar; Nicholas W C Dorsch
Journal:  Neurosurg Rev       Date:  2007-01-13       Impact factor: 3.042

2.  Spatial oxygenation profiles in tumors during normo- and hyperbaric hyperoxia.

Authors:  Oliver Thews; Peter Vaupel
Journal:  Strahlenther Onkol       Date:  2015-07-02       Impact factor: 3.621

3.  Topical oxygen therapy induces vascular endothelial growth factor expression and improves closure of clinically presented chronic wounds.

Authors:  Gayle M Gordillo; Sashwati Roy; Savita Khanna; Richard Schlanger; Sorabh Khandelwal; Gary Phillips; Chandan K Sen
Journal:  Clin Exp Pharmacol Physiol       Date:  2008-04-21       Impact factor: 2.557

4.  Hyperoxia retards growth and induces apoptosis, changes in vascular density and gene expression in transplanted gliomas in nude rats.

Authors:  Linda Elin Birkhaug Stuhr; A Raa; A M Oyan; K H Kalland; P O Sakariassen; K Petersen; R Bjerkvig; R K Reed
Journal:  J Neurooncol       Date:  2007-06-08       Impact factor: 4.130

Review 5.  Old but new methods in radiation oncology: hyperbaric oxygen therapy.

Authors:  Kazuhiko Ogawa; Kiyotaka Kohshi; Syogo Ishiuchi; Masayuki Matsushita; Naoki Yoshimi; Sadayuki Murayama
Journal:  Int J Clin Oncol       Date:  2013-03-05       Impact factor: 3.402

6.  Hypoxia in head and neck squamous cell carcinoma.

Authors:  John Zenghong Li; Wei Gao; Jimmy Yu-Wai Chan; Wai-Kuen Ho; Thian-Sze Wong
Journal:  ISRN Otolaryngol       Date:  2012-10-16

7.  Hyperoxia retards growth and induces apoptosis and loss of glands and blood vessels in DMBA-induced rat mammary tumors.

Authors:  Anette Raa; Christine Stansberg; Vidar M Steen; Rolf Bjerkvig; Rolf K Reed; Linda E B Stuhr
Journal:  BMC Cancer       Date:  2007-01-30       Impact factor: 4.430

8.  Non-Toxic Metabolic Management of Metastatic Cancer in VM Mice: Novel Combination of Ketogenic Diet, Ketone Supplementation, and Hyperbaric Oxygen Therapy.

Authors:  A M Poff; N Ward; T N Seyfried; P Arnold; D P D'Agostino
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

Review 9.  Challenges of Using High-Dose Fractionation Radiotherapy in Combination Therapy.

Authors:  Ying-Chieh Yang; Chi-Shiun Chiang
Journal:  Front Oncol       Date:  2016-06-30       Impact factor: 6.244

10.  Hyperoxia sensitizes hypoxic HeLa cells to ionizing radiation by downregulating HIF‑1α and VEGF expression.

Authors:  Dan Dong; Yan Fu; Feng Chen; Jing Zhang; Haiyan Jia; Jia Li; Huailin Wang; Jihong Wen
Journal:  Mol Med Rep       Date:  2020-11-20       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.